Calif. to investigate state stem cell agency

A California state political oversight commission has agreed to investigate a conflict of interest complaint filed against a board member at the state's stem cell agency. California's Fair Political Practices Commission said yesterday (Dec 10) that it will look into an linkurl:incident;http://www.the-scientist.com/blog/display/53971/ involving John Reed, a member of the California Institute of Regenerative Medicine's (CIRM) governing board and CEO of the Burnham Institute for Medical Research i

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A California state political oversight commission has agreed to investigate a conflict of interest complaint filed against a board member at the state's stem cell agency. California's Fair Political Practices Commission said yesterday (Dec 10) that it will look into an linkurl:incident;http://www.the-scientist.com/blog/display/53971/ involving John Reed, a member of the California Institute of Regenerative Medicine's (CIRM) governing board and CEO of the Burnham Institute for Medical Research in La Jolla. In August, Reed violated CIRM conflict of interest rules by writing a letter to a CIRM staff member seeking to overturn a decision not to award a grant to a Burnham researcher. A spokesperson for the Fair Political Practices Commission (FPPC) told __The Scientist__ that "the commission is moving forward with an investigation," but would not comment more specifically on the investigation. He did say that when FPPC investigations determine wrongdoing, fines may be levied against the guilty parties. The Foundation for Taxpayer and Consumer Rights (FTCR), a watchdog group that has been critical of CIRM since the institute's inception in 2004, filed the complaint two weeks ago. John Simpson, FTCR's stem cell project director, said in a press release announcing the impending investigation: "Most of the people handing out the money are the very same people from the institutions that get the money. That means the conflict rules in place must be strictly adhered to and there must be consequences when they are violated." Simpson has called for the resignation of Reed and CIRM board chairman linkurl:Robert Klein,;http://www.the-scientist.com/news/display/53480/ who suggested that Reed write the letter.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo